Company: ZVRA
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001628280-25-039967
Chunk: 45

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 45
---
ITEM 1.FINANCIAL STATEMENTS

ZEVRA THERAPEUTICS, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and par value amounts)

June 30,2025December 31,2024AssetsCurrent assets:Cash and cash equivalents$47,712 $33,785 Securities at fair value, current154,899 35,711 Accounts and other receivables18,266 10,509 Prepaid expenses and other current assets4,352 4,052 Inventories, current1,108 1,970 Total current assets226,337 86,027 Securities at fair value, noncurrent15,089 6,010 Inventories, noncurrent782 10,999 Property and equipment, net599 356 Operating lease right-of-use assets1,496 657 Goodwill4,701 4,701 Intangible assets, net7,053 68,993 Other long-term assets220 384 Total assets$256,277 $178,127 Liabilities and stockholders' equityCurrent liabilities:Accounts payable and accrued expenses$15,842 $25,456 Current portion of operating lease liabilities525 420 Current portion of discount and rebate liabilities5,599 4,989 Other current liabilities6,866 3,200 Total current liabilities28,832 34,065 Long-term debt60,692 59,504 Warrant liability15,807 17,804 Income tax payable17,479 14,431 Operating lease liabilities, less current portion1,059 372 Discount and rebate liabilities, less current portion11,862 7,655 Other long-term liabilities3,316 4,630 Total liabilities139,047 138,461 Commitments and contingencies (Note M)Stockholders’ equity:Preferred stock:Undesignated preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued or outstanding as of June 30, 2025, or December 31, 2024— — Common stock, $0.0001 par value, 250,000,000 shares authorized; 56,659,896 shares issued and 55,084,204 shares outstanding as of June 30, 2025; 55,246,401